429 related articles for article (PubMed ID: 11138011)
1. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease.
Brenner M; Johnson AB; Boespflug-Tanguy O; Rodriguez D; Goldman JE; Messing A
Nat Genet; 2001 Jan; 27(1):117-20. PubMed ID: 11138011
[TBL] [Abstract][Full Text] [Related]
2. GFAP mutations in Alexander disease.
Li R; Messing A; Goldman JE; Brenner M
Int J Dev Neurosci; 2002; 20(3-5):259-68. PubMed ID: 12175861
[TBL] [Abstract][Full Text] [Related]
3. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K
Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771
[TBL] [Abstract][Full Text] [Related]
4. The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27.
Der Perng M; Su M; Wen SF; Li R; Gibbon T; Prescott AR; Brenner M; Quinlan RA
Am J Hum Genet; 2006 Aug; 79(2):197-213. PubMed ID: 16826512
[TBL] [Abstract][Full Text] [Related]
5. The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease.
Sosunov AA; McKhann GM; Goldman JE
Acta Neuropathol Commun; 2017 Mar; 5(1):27. PubMed ID: 28359321
[TBL] [Abstract][Full Text] [Related]
6. Molecular findings in symptomatic and pre-symptomatic Alexander disease patients.
Gorospe JR; Naidu S; Johnson AB; Puri V; Raymond GV; Jenkins SD; Pedersen RC; Lewis D; Knowles P; Fernandez R; De Vivo D; van der Knaap MS; Messing A; Brenner M; Hoffman EP
Neurology; 2002 May; 58(10):1494-500. PubMed ID: 12034785
[TBL] [Abstract][Full Text] [Related]
7. Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease.
Pekny T; Faiz M; Wilhelmsson U; Curtis MA; Matej R; Skalli O; Pekny M
APMIS; 2014 Jan; 122(1):76-80. PubMed ID: 23594359
[TBL] [Abstract][Full Text] [Related]
8. Novel deletion mutation in GFAP gene in an infantile form of Alexander disease.
Murakami N; Tsuchiya T; Kanazawa N; Tsujino S; Nagai T
Pediatr Neurol; 2008 Jan; 38(1):50-2. PubMed ID: 18054694
[TBL] [Abstract][Full Text] [Related]
9. A case of infantile Alexander disease accompanied by infantile spasms diagnosed by DNA analysis.
Lee JM; Kim AS; Lee SJ; Cho SM; Lee DS; Choi SM; Kim DK; Ki CS; Kim JW
J Korean Med Sci; 2006 Oct; 21(5):954-7. PubMed ID: 17043438
[TBL] [Abstract][Full Text] [Related]
10. Alexander disease: a review and the gene.
Johnson AB
Int J Dev Neurosci; 2002; 20(3-5):391-4. PubMed ID: 12175878
[TBL] [Abstract][Full Text] [Related]
11. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease.
Li R; Johnson AB; Salomons G; Goldman JE; Naidu S; Quinlan R; Cree B; Ruyle SZ; Banwell B; D'Hooghe M; Siebert JR; Rolf CM; Cox H; Reddy A; Gutiérrez-Solana LG; Collins A; Weller RO; Messing A; van der Knaap MS; Brenner M
Ann Neurol; 2005 Mar; 57(3):310-26. PubMed ID: 15732097
[TBL] [Abstract][Full Text] [Related]
12. Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP.
Hsiao VC; Tian R; Long H; Der Perng M; Brenner M; Quinlan RA; Goldman JE
J Cell Sci; 2005 May; 118(Pt 9):2057-65. PubMed ID: 15840648
[TBL] [Abstract][Full Text] [Related]
13. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease.
Tian R; Gregor M; Wiche G; Goldman JE
Am J Pathol; 2006 Mar; 168(3):888-97. PubMed ID: 16507904
[TBL] [Abstract][Full Text] [Related]
14. Effects of Alexander disease-associated mutations on the assembly and organization of GFAP intermediate filaments.
Yang AW; Lin NH; Yeh TH; Snider N; Perng MD
Mol Biol Cell; 2022 Jul; 33(8):ar69. PubMed ID: 35511821
[TBL] [Abstract][Full Text] [Related]
15. Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model.
Lee SH; Nam TS; Kim KH; Kim JH; Yoon W; Heo SH; Kim MJ; Shin BA; Perng MD; Choy HE; Jo J; Kim MK; Choi SY
BMC Neurol; 2017 Sep; 17(1):175. PubMed ID: 28882119
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic study in Chinese patients with Alexander disease.
Ye Wu ; Qiang Gu ; Jingmin Wang ; Yanling Yang ; Xiru Wu ; Yuwu Jiang
J Child Neurol; 2008 Feb; 23(2):173-7. PubMed ID: 18079314
[TBL] [Abstract][Full Text] [Related]
17. Astrocytic TDP-43 pathology in Alexander disease.
Walker AK; Daniels CM; Goldman JE; Trojanowski JQ; Lee VM; Messing A
J Neurosci; 2014 May; 34(19):6448-58. PubMed ID: 24806671
[TBL] [Abstract][Full Text] [Related]
18. Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease.
Hagemann TL; Boelens WC; Wawrousek EF; Messing A
Hum Mol Genet; 2009 Apr; 18(7):1190-9. PubMed ID: 19129171
[TBL] [Abstract][Full Text] [Related]
19. Juvenile Alexander disease with a novel mutation in glial fibrillary acidic protein gene.
Sawaishi Y; Yano T; Takaku I; Takada G
Neurology; 2002 May; 58(10):1541-3. PubMed ID: 12034796
[TBL] [Abstract][Full Text] [Related]
20. Screening for GFAP rearrangements in a cohort of Alexander disease and undetermined leukoencephalopathy patients.
Ferreira MC; Dorboz I; Rodriguez D; Boespflug Tanguy O
Eur J Med Genet; 2015 Sep; 58(9):466-70. PubMed ID: 26208460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
